Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Asset Utilization Ratio (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Asset Utilization Ratio for 12 consecutive years, with 0.61 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 4.51% to 0.61 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.61, a 4.51% decrease, with the full-year FY2025 number at 0.55, down 15.15% from a year prior.
  • Asset Utilization Ratio was 0.61 for Q4 2025 at Ekso Bionics Holdings, down from 0.66 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.66 in Q3 2025 to a low of 0.13 in Q2 2021.
  • A 5-year average of 0.43 and a median of 0.48 in 2023 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: tumbled 69.72% in 2021, then soared 125.52% in 2023.
  • Ekso Bionics Holdings' Asset Utilization Ratio stood at 0.14 in 2021, then soared by 121.92% to 0.32 in 2022, then soared by 90.95% to 0.61 in 2023, then rose by 5.51% to 0.64 in 2024, then fell by 4.51% to 0.61 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Asset Utilization Ratio are 0.61 (Q4 2025), 0.66 (Q3 2025), and 0.58 (Q2 2025).